Rapt Therapeutics Inc (RAPT)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart
Ticker: RAPT Exchange: NMS


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2021-05-13 2021-05-11 PS Planned sale

Brockstedt Dirk G.

Chief Scientific Officer

Officer
2,648 -11.8%
18.19
48,167 USD 		2,648 -11.8% 18.19 48,167 USD
2021-05-05 2021-05-03 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
1,000 -1.5%
22.04
22,040 USD 		1,000 -1.5% 22.04 22,040 USD
2021-04-16 2021-04-15 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
1,000 -1.6%
21.14
21,140 USD 		1,000 -1.6% 21.14 21,140 USD
2021-04-14 2021-04-13 B Purchase

Robbins Wendye

Non-Executive Director
300 +5.2%
19.40
5,820 USD 		300 +5.2% 19.40 5,820 USD
2021-04-14 2021-04-13 B Purchase

Robbins Wendye

Non-Executive Director
400 +7.4%
19.50
7,800 USD 		400 +7.4% 19.50 7,800 USD
2021-04-01 2021-04-01 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
1,000 -1.5%
22.66
22,660 USD 		1,000 -1.5% 22.66 22,660 USD
2021-03-17 2021-03-15 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
1,000 -1.5%
21.91
21,910 USD 		1,000 -1.5% 21.91 21,910 USD
2021-03-02 2021-03-01 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
1,000 -1.5%
18.60
18,600 USD 		1,000 -1.5% 18.60 18,600 USD
2021-02-17 2021-02-16 PS Planned sale

Brockstedt Dirk G.

Chief Scientific Officer

Officer
9,877 -33.3%
21.22
209,590 USD 		9,877 -33.3% 21.22 209,590 USD
2021-02-17 2021-02-16 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
1,000 -1.5%
21.81
21,810 USD 		1,000 -1.5% 21.81 21,810 USD
2021-02-02 2021-02-01 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
1,000 -1.5%
19.99
19,990 USD 		1,000 -1.5% 19.99 19,990 USD
2021-01-15 2021-01-15 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
831 -1.2%
21.05
17,493 USD 		831 -1.2% 21.05 17,493 USD
2021-01-15 2021-01-15 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
169 -0.2%
21.05
3,557 USD 		169 -0.2% 21.05 3,557 USD
2021-01-06 2021-01-06 PS Planned sale

Brockstedt Dirk G.

Chief Scientific Officer

Officer
1,179 -6.3%
19.68
23,203 USD 		1,179 -6.3% 19.68 23,203 USD
2021-01-06 2021-01-05 S Sale

Brockstedt Dirk G.

Chief Scientific Officer

Officer
821 -4.2%
19.76
16,225 USD 		821 -4.2% 19.76 16,225 USD
2021-01-04 2021-01-04 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
775 -1.1%
19.75
15,306 USD 		775 -1.1% 19.75 15,306 USD
2021-01-04 2021-01-04 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
225 -0.3%
19.75
4,444 USD 		225 -0.3% 19.75 4,444 USD
2020-12-15 2020-12-15 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
795 -1.1%
24.55
19,517 USD 		795 -1.1% 24.55 19,517 USD
2020-12-15 2020-12-15 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
205 -0.3%
24.55
5,033 USD 		205 -0.3% 24.55 5,033 USD
2020-12-01 2020-12-01 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
524 -0.7%
21.83
11,439 USD 		524 -0.7% 21.83 11,439 USD
2020-12-01 2020-12-01 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
476 -0.7%
21.83
10,391 USD 		476 -0.7% 21.83 10,391 USD
2020-11-23 2020-11-19 B Purchase

Robbins Wendye

Non-Executive Director
500 +inf%
16.09
8,045 USD 		500 +inf% 16.09 8,045 USD
2020-11-23 2020-11-19 B Purchase

Robbins Wendye

Non-Executive Director
500 +10.9%
16.08
8,040 USD 		500 +10.9% 16.08 8,040 USD
2020-11-20 2020-11-19 B Purchase

RIEFLIN WILLIAM JL

Non-Executive Director
10,000 +125.0%
16.22
162,200 USD 		10,000 +125.0% 16.22 162,200 USD
2020-11-18 2020-11-16 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
1,000 -1.4%
20.25
20,250 USD 		1,000 -1.4% 20.25 20,250 USD
2020-11-18 2020-11-16 PS Planned sale

Brockstedt Dirk G.

Chief Scientific Officer

Officer
9,877 -49.1%
17.01
168,008 USD 		9,877 -49.1% 17.01 168,008 USD
2020-11-03 2020-11-02 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
1,000 -1.5%
28.06
28,060 USD 		1,000 -1.5% 28.06 28,060 USD
2020-11-03 2020-11-02 PS Planned sale

Lam Karen C

VP, Finance and Controller

Officer
2,022 -13.7%
28.14
56,899 USD 		2,022 -13.7% 28.14 56,899 USD
2020-11-03 2020-11-02 PS Planned sale

Brockstedt Dirk G.

Chief Scientific Officer

Officer
1,910 -15.7%
28.06
53,595 USD 		1,910 -15.7% 28.06 53,595 USD
2020-10-16 2020-10-15 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
1,000 -1.5%
35.76
35,760 USD 		1,000 -1.5% 35.76 35,760 USD
2020-10-13 2020-10-12 PS Planned sale

Wong Brian Russell

President and CEO

Executive Director
20,000 -5.6%
40.05
801,040 USD 		20,000 -5.6% 40.05 801,040 USD
2020-10-13 2020-10-12 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
2,000 -2.9%
40.20
80,400 USD 		2,000 -2.9% 40.20 80,400 USD
2020-10-02 2020-10-01 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
1,000 -1.4%
31.18
31,180 USD 		1,000 -1.4% 31.18 31,180 USD
2020-09-29 2020-09-28 B Purchase

Robbins Wendye

Non-Executive Director
200 +3.1%
28.55
5,710 USD 		200 +3.1% 28.55 5,710 USD
2020-09-29 2020-09-28 B Purchase

Robbins Wendye

Non-Executive Director
300 +5.0%
28.80
8,640 USD 		300 +5.0% 28.80 8,640 USD
2020-09-24 2020-09-24 B Purchase

Robbins Wendye

Non-Executive Director
200 +3.4%
28.00
5,600 USD 		200 +3.4% 28.00 5,600 USD
2020-09-24 2020-09-23 B Purchase

Robbins Wendye

Non-Executive Director
100 +1.7%
29.50
2,950 USD 		100 +1.7% 29.50 2,950 USD
2020-09-24 2020-09-23 B Purchase

Robbins Wendye

Non-Executive Director
300 +5.5%
29.10
8,730 USD 		300 +5.5% 29.10 8,730 USD
2020-09-23 2020-09-23 B Purchase

Wong Brian Russell

President and CEO

Executive Director
2,000 +0.6%
30.06
60,120 USD 		2,000 +0.6% 30.06 60,120 USD
2020-09-23 2020-09-22 S Sale

COLUMN GROUP II, LP

General Partner

Major owner
608,000 -13.7%
30.85
18,756,800 USD 		608,000 -13.7% 30.85 18,756,800 USD
2020-09-22 2020-09-22 S Sale

Svennilson Peter

Non-Executive Director Major owner
608,000 -13.7%
30.85
18,756,800 USD 		608,000 -13.7% 30.85 18,756,800 USD
2020-09-15 2020-09-15 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
1,000 -1.5%
36.14
36,140 USD 		1,000 -1.5% 36.14 36,140 USD
2020-09-02 2020-09-01 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
1,000 -1.5%
26.24
26,240 USD 		1,000 -1.5% 26.24 26,240 USD
2020-08-19 2020-08-17 S Sale

Svennilson Peter

Non-Executive Director Major owner
538,654 -10.8%
22.75
12,254,379 USD 		538,654 -10.8% 22.75 12,254,379 USD
2020-08-19 2020-08-17 S Sale

COLUMN GROUP II, LP

General Partner

Major owner
538,654 -10.8%
22.75
12,254,379 USD 		538,654 -10.8% 22.75 12,254,379 USD
2020-08-18 2020-08-17 PS Planned sale

Brockstedt Dirk G.

Chief Scientific Officer

Officer
8,375 -45.0%
24.07
201,586 USD 		8,375 -45.0% 24.07 201,586 USD
2020-08-18 2020-08-17 PS Planned sale

Brockstedt Dirk G.

Chief Scientific Officer

Officer
1,502 -7.5%
23.13
34,741 USD 		1,502 -7.5% 23.13 34,741 USD
2020-08-18 2020-08-17 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
1,000 -1.4%
24.76
24,760 USD 		1,000 -1.4% 24.76 24,760 USD
2020-08-03 2020-08-03 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
1,000 -1.4%
21.54
21,540 USD 		1,000 -1.4% 21.54 21,540 USD
2020-07-27 2020-07-24 B Purchase

Robbins Wendye

Non-Executive Director
400 +7.9%
22.75
9,100 USD 		400 +7.9% 22.75 9,100 USD
2020-07-27 2020-07-24 B Purchase

Robbins Wendye

Non-Executive Director
500 +11.0%
22.25
11,125 USD 		500 +11.0% 22.25 11,125 USD
2020-07-16 2020-07-15 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
1,000 -1.4%
28.76
28,760 USD 		1,000 -1.4% 28.76 28,760 USD
2020-07-01 2020-07-01 B Purchase

Robbins Wendye

Non-Executive Director
500 +12.3%
26.30
13,150 USD 		500 +12.3% 26.30 13,150 USD
2020-07-01 2020-07-01 B Purchase

Robbins Wendye

Non-Executive Director
500 +14.1%
26.50
13,250 USD 		500 +14.1% 26.50 13,250 USD
2020-07-01 2020-07-01 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
1,000 -1.4%
28.61
28,610 USD 		1,000 -1.4% 28.61 28,610 USD
2020-07-01 2020-06-29 B Purchase

Robbins Wendye

Non-Executive Director
1,600 +82.1%
25.77
41,232 USD 		1,600 +82.1% 25.77 41,232 USD
2020-06-26 2020-06-25 S Sale

Giordano Michael F

Non-Executive Director
19,013 -100.0%
33.37
634,464 USD 		19,013 -100.0% 33.37 634,464 USD
2020-06-26 2020-06-25 PS Planned sale

Lam Karen C

VP, Finance & Controller

Officer
875 -6.4%
35.00
30,625 USD 		875 -6.4% 35.00 30,625 USD
2020-06-18 2020-06-15 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
1,000 -1.4%
20.95
20,950 USD 		1,000 -1.4% 20.95 20,950 USD
2020-06-02 2020-06-01 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
1,000 -1.3%
18.50
18,500 USD 		1,000 -1.3% 18.50 18,500 USD
2020-05-29 2020-05-26 S Sale

Topspin Fund L.P.

Major owner
2,056,666
0.00
0 USD 		2,056,666 0.00 0 USD
2020-05-22 2020-05-22 PS Planned sale

HO WILLIAM

Chief Medical Officer

Officer
7,500 -9.1%
18.02
135,150 USD 		7,500 -9.1% 18.02 135,150 USD
2020-05-18 2020-05-15 PS Planned sale

Brockstedt Dirk G.

Chief Scientific Officer

Officer
9,877 -49.1%
15.00
148,155 USD 		9,877 -49.1% 15.00 148,155 USD
2020-05-08 2020-05-07 PS Planned sale

Lam Karen C

VP, Finance & Controller

Officer
1,831 -14.5%
15.40
28,197 USD 		1,831 -14.5% 15.40 28,197 USD
2019-11-15 2019-11-04 B Purchase

Topspin Fund L.P.

Major owner
415,000 +19.2%
12.00
4,980,000 USD 		415,000 +19.2% 12.00 4,980,000 USD
2019-11-04 2019-11-04 B Purchase

RIEFLIN WILLIAM JL

Non-Executive Director
8,000 +inf%
12.00
96,000 USD 		8,000 +inf% 12.00 96,000 USD
2019-11-04 2019-11-04 B Purchase

Robbins Wendye

Non-Executive Director
1,600 +inf%
12.00
19,200 USD 		1,600 +inf% 12.00 19,200 USD
2019-11-04 2019-11-04 B Purchase

GOEDDEL DAVID V

Non-Executive Director Major owner
625,000 +14.3%
12.00
7,500,000 USD 		625,000 +14.3% 12.00 7,500,000 USD
2019-11-04 2019-11-04 B Purchase

COLUMN GROUP II, LP

General Partner

Major owner
625,000 +14.3%
12.00
7,500,000 USD 		625,000 +14.3% 12.00 7,500,000 USD
2019-11-04 2019-11-04 B Purchase

Wong Brian Russell

President and CEO

Executive Director
25,000 +25.0%
12.00
300,000 USD 		25,000 +25.0% 12.00 300,000 USD